PHARMOCOECONOMICS OF DIABETES
The diabetes is a serious problem for public health services which affects persons of any age and results in long loss of health and early death of patients. Under forecasts of experts, by 2010 221 million person will be suffer from diabetes-2. This fact attaches to disease character of global «not infectious epidemic» which continues to expand without dependence from a гасе of people or a level of economic development of country. Diabetes is heavy economic burden in Russia. By estimates only direct costs on maintenance with medical aid of patients with diabetes in Russia should be more than 8,5 billions of $ USA per one year. All-round pharmacoeconomical estimation of therapy of a diabetes with use of modern methods of modeling should improve medicinal maintenance of patients with this disease.